Raymond James & Associates Reviva Pharmaceuticals Holdings, Inc. Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
BUY
$0.14 - $2.66 $1,820 - $34,580
13,000 Added 65.0%
33,000 $52,000
Q2 2022

Aug 12, 2022
BUY
$1.03 - $2.47 $6,180 - $14,820
6,000 Added 42.86%
20,000 $22,000
Q1 2022

May 11, 2022
BUY
$1.61 - $3.01 $22,540 - $42,140
14,000 New
14,000 $34,000

Others Institutions Holding RVPH

# of Institutions
40
Shares Held
9.97M
Call Options Held
133K
Put Options Held
43.9K
View Full List

About REVIVA PHARMACEUTICALS HOLDINGS, INC.

RVPH Quotes by TradingView
  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $36.8M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email